<DOC>
	<DOCNO>NCT02329964</DOCNO>
	<brief_summary>This study compare rocuronium-sugammadex succinylcholine LMS surgery characterize short operation time , require intense paralysis ambulatory setting , investigate .</brief_summary>
	<brief_title>Effectiveness Sugammadex LMS Surgery</brief_title>
	<detailed_description>Laser microlaryngeal surgery ( LMS ) require brief intense paralysis short operation time ambulatory setting . The ideal muscle relaxant rapid onset time , short duration action minimal side effect yet available . Succinylcholine ( SCC ) commonly use muscle relaxant LMS rapid onset time short duration action . The use SCC tracheal intubation usually follow repeat small bolus drip SCC small bolus nondepolarizing muscle relaxant intermediate duration . As alternative SCC , non-depolarizing neuromuscular blocking agent rocuronium use LMS . The onset rocuronium 1mg/kg around 60 similar SCC . However high dos rocuronium long duration action ; inappropriate ambulatory surgery require rapid recovery neuromuscular function rapid turnover . Sugammadex recently introduce selective relaxant-binding agent allow rapid reversal rocuronium-induced neuromuscular blockade . Even profound neuromuscular block rocuronium quickly antagonize sugammadex . After obtain Institutional Review Board approval write informed consent , 80 patient enrol study . Patients divide two group randomly Rocuronium-Sugammadex group ( R-S group ) Succinylcholine - Cisatracurium- Neostigmine group ( S-C-N group ) . Anesthesia induce intravenous propofol 1.5-2.5 mg/kg , together fentanyl1.5 mcg/kg After induction anesthesia , neuromuscular monitoring perform continuously adductor pollicis muscle acceleromyography ( TOF-Watch® ) . Subsequently , R-S group , patient receive rocuronium 1mg/kg S-C-N group , patient receive SCC 1mg/kg . After T1 assess zero neuromuscular monitoring , endotracheal intubation perform . After endotracheal intubation , S-C-N group , cisatracurium 0.08mg/kg injected R-S group , volume normal saline inject . Anesthesia maintain desflurane air surgery . Additive dose rocuronium 0.15mg/kg SCC 10mg give necessary ensure neuromuscular blockade remain T2 surgery . After surgical procedure end , patient receive sugammadex 2mg/kg R-S group , pyridostigmine 0.2 mg/kg atropine 10mcg/kg S-C-N group appearance second TOF twitch ( T2 ) . Patient assess time recovery TOF ratio 0.9 , surgical rating scale ( 1- extremely poor condition , 2- poor condition , 3- acceptable condition , 4- good condition , 5- optimal condition ) , anesthesia time .</detailed_description>
	<mesh_term>Neostigmine</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<mesh_term>Rocuronium</mesh_term>
	<mesh_term>Cisatracurium</mesh_term>
	<mesh_term>Succinylcholine</mesh_term>
	<criteria>American Society Anesthesiologist [ ASA ] class 13 schedule Laser microlaryngeal surgery general anesthesia write informed consent suspect difficult tracheal intubation disorder affect neuromuscular blockade know suspected significant renal dysfunction know suspect severe hepatic dysfunction history malignant hyperthermia allergy opioids , neuromuscular block drug medication use general anesthesia contraindication pyridostigmine and/or atropine pregnancy breast feed body mass index &gt; 27kg/m2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Rocuronium</keyword>
	<keyword>Sugammadex</keyword>
	<keyword>Succinylcholine</keyword>
	<keyword>Cisatracurium</keyword>
	<keyword>Neostigmine</keyword>
	<keyword>acceleromyography ( TOF-Watch® )</keyword>
</DOC>